CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
APAC
CANADA

About Us

Conference

Partner With Us

  • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    BioTech
    Cell and Gene Therapy
    Clinical Trial
    Drug Discovery and Development
    Life Science AI
    Regenerative Medicine
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    Blood Bank
    CDMO
    Clinical Laboratory
    CRO
    Life Science Testing
    Skin Care
    Supplements
  • Business Services
    Life Science Consulting
    Life Science Facility Service
    Life Science Financial Services
    Life Science Marketing
    Life Science Recruitment Firms
    Pharma Wholesale and Distribution
    Pharmacy Management
    Regulatory and Compliance
    Regulatory Services
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Magazines
  • CXO Awards
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

A featured contribution from Leadership Perspectives: a curated forum reserved for leaders nominated by our subscribers and vetted by our Life Sciences Review Advisory Board.

UT Southwestern Medical Center

Yunus Emre Tarhan, Assistant Professor of Medicine

Medicare Reform: Addressing Financial Sustainability Urgency

Yunus Emre Tarhan

Yunus Emre Tarhan

In the last 100 years, the American health system has undergone multiple reforms and changes that have been crucial in providing higher quality healthcare. From unregulated hospitals and non-existent insurance systems to today’s strictly regulated hospital systems, insurance coverages played a huge role in providing this quality of care. There have been many vital reforms in this field but creation of CMS- Medicare and Medicaid by far the most significant one and the very institution is also at the core of hot debate about future of healthcare today.


Changes in Social Determinants of Health and Cost


United States went through tremendous shift at socioeconomic and cultural level in the last 50 years and had a huge impact on healthcare and health spending. In 2020 health spending in US increased by 9.7% to 4.1 trillion dollars which was higher than usual growth annually likely due to pandemic according to American Medical Association.


The hospital insurance trust fund, also known as Part A of Medicare, finances health care services related to stays in hospitals, skilled nursing facilities, and hospices for eligible beneficiaries in the Medicare program. This fund is mainly funded by the 2.9% payroll tax paid by workers and employers equally. In contrast, the Medicare Part B and D federal trust fund is mainly funded by beneficiary premiums and revenue from the federal government.


Our country has an aging population, and Medicare beneficiaries are growing in number every year, along with health spending due to changes in technology, novel medical treatments, etc. It is expected that the MHI Fund will become insolvent by 2028 (Figures 1 and 2). The insolvency problem is only faced by the Hospital Insurance Fund, and a coverage cut of about 10% is expected if no reform takes place before 2028.


Dire Need for Reform


We are in a situation where growing health spending, aging population, emerging novel therapies and so many other contributing factors turns the problem into a conundrum that requires creative thinking to alleviate the burden from federal government, and in return it will not be only an intervention that will postpone the problem.


First time in history we have more people above 65 years old than less than 5 years old. While our nation is aging fast also number of childless elderly people are also growing and highest in history currently around 19%. This makes it essential that time is now to act otherwise every year eligible candidates for this program will be less and less.


To preserve the rights and coverage given to our citizens with Medicare program, we need to put it on sustainable financial path.


There are multiple other ways of increasing revenue, raising tax rates, expanding taxes i.e., or reducing cost by adjusting coverages, modernizing cost sharing rules etc. Historically, these measures fell short in creating sustained solutions rather delayed the problem. Alternative ideas should also be entertained like adjusting family plans from nuclear family to extended family; including our parents in the qualified employer-based insurance coverages with premium adjustments would provide much needed reduction in the number of beneficiaries covered via this fund.


Figure 1: CMS 2021 Annual Report of the Boards of Trustees of the Federal Hospital Insurance. Burden on General Fund is higher every year, leading to fund insolvency.


Figure2: Social Security Administration, 2022 Annual Report of the Board of Trustees. Medicare HI FUND will be depleted and score deficit moving forward every year.


The articles from these contributors are based on their personal expertise and viewpoints, and do not necessarily reflect the opinions of their employers or affiliated organizations.
The Leadership Perspectives forum brings together voices shaping the future of life sciences. It features leaders who are advancing change across the industry through strategic leadership and applied insight.
EDITOR'S CHOICE
  • Willis Towers Watson

    ICON [NASDAQ: ICLR]

    The Significant Increase in Demand for Clinical Research Associates (CRAs)

    Helen Yeardley, Executive Vice President, ICON [NASDAQ: ICLR]

  • Willis Towers Watson

    PacBio [NASDAQ: PACB]

    The Talent - Culture Continuum: How to Manage an Innovation Culture Amid Growth and Change

    Alvin Hom, Head of Global Talent Acquisition, PacBio [NASDAQ: PACB]

  • Willis Towers Watson

    Repligen Corp [NASDAQ: RGEN]

    Gene Therapy-Therapeutic Viral Vectors; Manufacturing, Challenges, and Innovation

    Rachel Legmann, PhD, Senior Director of Technology, Gene Therapy, Repligen Corp

  • Willis Towers Watson

    Ionis Pharmaceuticals [NASDAQ: IONS]

    Bridging the Diversity Divide

    Victoria Sanjurjo, Medical Director, Clinical Development, Ionis Pharmaceuticals, Inc [NASDAQ: IONS]

Life Sciences Review
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/leadership-perspective/medicare-reform-addressing-financial-sustainability-urgency-nwid-3290.html